These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 20207481)

  • 1. Research design considerations for confirmatory chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Peirce-Sandner S; Baron R; Bellamy N; Burke LB; Chappell A; Chartier K; Cleeland CS; Costello A; Cowan P; Dimitrova R; Ellenberg S; Farrar JT; French JA; Gilron I; Hertz S; Jadad AR; Jay GW; Kalliomäki J; Katz NP; Kerns RD; Manning DC; McDermott MP; McGrath PJ; Narayana A; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Reeve BB; Rhodes T; Sampaio C; Simpson DM; Stauffer JW; Stucki G; Tobias J; White RE; Witter J
    Pain; 2010 May; 149(2):177-193. PubMed ID: 20207481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Research design considerations for single-dose analgesic clinical trials in acute pain: IMMPACT recommendations.
    Cooper SA; Desjardins PJ; Turk DC; Dworkin RH; Katz NP; Kehlet H; Ballantyne JC; Burke LB; Carragee E; Cowan P; Croll S; Dionne RA; Farrar JT; Gilron I; Gordon DB; Iyengar S; Jay GW; Kalso EA; Kerns RD; McDermott MP; Raja SN; Rappaport BA; Rauschkolb C; Royal MA; Segerdahl M; Stauffer JW; Todd KH; Vanhove GF; Wallace MS; West C; White RE; Wu C
    Pain; 2016 Feb; 157(2):288-301. PubMed ID: 26683233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic low back pain analgesic studies--a methodological minefield.
    Moore AR; Straube S; Derry S; McQuay HJ
    Pain; 2010 Jun; 149(3):431-434. PubMed ID: 20304558
    [No Abstract]   [Full Text] [Related]  

  • 4. Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations.
    Turk DC; Dworkin RH; Burke LB; Gershon R; Rothman M; Scott J; Allen RR; Atkinson HJ; Chandler J; Cleeland C; Cowan P; Dimitrova R; Dionne R; Farrar JT; Haythornthwaite JA; Hertz S; Jadad AR; Jensen MP; Kellstein D; Kerns RD; Manning DC; Martin S; Max MB; McDermott MP; McGrath P; Moulin DE; Nurmikko T; Quessy S; Raja S; Rappaport BA; Rauschkolb C; Robinson JP; Royal MA; Simon L; Stauffer JW; Stucki G; Tollett J; von Stein T; Wallace MS; Wernicke J; White RE; Williams AC; Witter J; Wyrwich KW
    Pain; 2006 Dec; 125(3):208-215. PubMed ID: 17069973
    [No Abstract]   [Full Text] [Related]  

  • 5. Research design considerations for chronic pain prevention clinical trials: IMMPACT recommendations.
    Gewandter JS; Dworkin RH; Turk DC; Farrar JT; Fillingim RB; Gilron I; Markman JD; Oaklander AL; Polydefkis MJ; Raja SN; Robinson JP; Woolf CJ; Ziegler D; Ashburn MA; Burke LB; Cowan P; George SZ; Goli V; Graff OX; Iyengar S; Jay GW; Katz J; Kehlet H; Kitt RA; Kopecky EA; Malamut R; McDermott MP; Palmer P; Rappaport BA; Rauschkolb C; Steigerwald I; Tobias J; Walco GA
    Pain; 2015 Jul; 156(7):1184-1197. PubMed ID: 25887465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Considerations for improving assay sensitivity in chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Peirce-Sandner S; Burke LB; Farrar JT; Gilron I; Jensen MP; Katz NP; Raja SN; Rappaport BA; Rowbotham MC; Backonja MM; Baron R; Bellamy N; Bhagwagar Z; Costello A; Cowan P; Fang WC; Hertz S; Jay GW; Junor R; Kerns RD; Kerwin R; Kopecky EA; Lissin D; Malamut R; Markman JD; McDermott MP; Munera C; Porter L; Rauschkolb C; Rice ASC; Sampaio C; Skljarevski V; Sommerville K; Stacey BR; Steigerwald I; Tobias J; Trentacosti AM; Wasan AD; Wells GA; Williams J; Witter J; Ziegler D
    Pain; 2012 Jun; 153(6):1148-1158. PubMed ID: 22494920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Wyrwich KW; Beaton D; Cleeland CS; Farrar JT; Haythornthwaite JA; Jensen MP; Kerns RD; Ader DN; Brandenburg N; Burke LB; Cella D; Chandler J; Cowan P; Dimitrova R; Dionne R; Hertz S; Jadad AR; Katz NP; Kehlet H; Kramer LD; Manning DC; McCormick C; McDermott MP; McQuay HJ; Patel S; Porter L; Quessy S; Rappaport BA; Rauschkolb C; Revicki DA; Rothman M; Schmader KE; Stacey BR; Stauffer JW; von Stein T; White RE; Witter J; Zavisic S
    J Pain; 2008 Feb; 9(2):105-21. PubMed ID: 18055266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving Study Conduct and Data Quality in Clinical Trials of Chronic Pain Treatments: IMMPACT Recommendations.
    Gewandter JS; Dworkin RH; Turk DC; Devine EG; Hewitt D; Jensen MP; Katz NP; Kirkwood AA; Malamut R; Markman JD; Vrijens B; Burke L; Campbell JN; Carr DB; Conaghan PG; Cowan P; Doyle MK; Edwards RR; Evans SR; Farrar JT; Freeman R; Gilron I; Juge D; Kerns RD; Kopecky EA; McDermott MP; Niebler G; Patel KV; Rauck R; Rice ASC; Rowbotham M; Sessler NE; Simon LS; Singla N; Skljarevski V; Tockarshewsky T; Vanhove GF; Wasan AD; Witter J
    J Pain; 2020; 21(9-10):931-942. PubMed ID: 31843583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with pain.
    Turk DC; Dworkin RH; Revicki D; Harding G; Burke LB; Cella D; Cleeland CS; Cowan P; Farrar JT; Hertz S; Max MB; Rappaport BA
    Pain; 2008 Jul; 137(2):276-285. PubMed ID: 17937976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations.
    Dworkin RH; Turk DC; Farrar JT; Haythornthwaite JA; Jensen MP; Katz NP; Kerns RD; Stucki G; Allen RR; Bellamy N; Carr DB; Chandler J; Cowan P; Dionne R; Galer BS; Hertz S; Jadad AR; Kramer LD; Manning DC; Martin S; McCormick CG; McDermott MP; McGrath P; Quessy S; Rappaport BA; Robbins W; Robinson JP; Rothman M; Royal MA; Simon L; Stauffer JW; Stein W; Tollett J; Wernicke J; Witter J;
    Pain; 2005 Jan; 113(1-2):9-19. PubMed ID: 15621359
    [No Abstract]   [Full Text] [Related]  

  • 11. Assessment of physical function and participation in chronic pain clinical trials: IMMPACT/OMERACT recommendations.
    Taylor AM; Phillips K; Patel KV; Turk DC; Dworkin RH; Beaton D; Clauw DJ; Gignac MAM; Markman JD; Williams DA; Bujanover S; Burke LB; Carr DB; Choy EH; Conaghan PG; Cowan P; Farrar JT; Freeman R; Gewandter J; Gilron I; Goli V; Gover TD; Haddox JD; Kerns RD; Kopecky EA; Lee DA; Malamut R; Mease P; Rappaport BA; Simon LS; Singh JA; Smith SM; Strand V; Tugwell P; Vanhove GF; Veasley C; Walco GA; Wasan AD; Witter J
    Pain; 2016 Sep; 157(9):1836-1850. PubMed ID: 27058676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methodological issues in clinical trials of opioids for chronic pain.
    Katz N
    Neurology; 2005 Dec; 65(12 Suppl 4):S32-49. PubMed ID: 16385103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.
    Dworkin RH; Katz J; Gitlin MJ
    Neurology; 2005 Dec; 65(12 Suppl 4):S7-19. PubMed ID: 16385107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations.
    Gewandter JS; Dworkin RH; Turk DC; McDermott MP; Baron R; Gastonguay MR; Gilron I; Katz NP; Mehta C; Raja SN; Senn S; Taylor C; Cowan P; Desjardins P; Dimitrova R; Dionne R; Farrar JT; Hewitt DJ; Iyengar S; Jay GW; Kalso E; Kerns RD; Leff R; Leong M; Petersen KL; Ravina BM; Rauschkolb C; Rice ASC; Rowbotham MC; Sampaio C; Sindrup SH; Stauffer JW; Steigerwald I; Stewart J; Tobias J; Treede RD; Wallace M; White RE
    Pain; 2014 Sep; 155(9):1683-1695. PubMed ID: 24865794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial outcome in neuropathic pain: relationship to study characteristics.
    Katz J; Finnerup NB; Dworkin RH
    Neurology; 2008 Jan; 70(4):263-72. PubMed ID: 17914067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Afterword: five steps to increase the payoff of chronic pain trials.
    Max MB
    Neurology; 2005 Dec; 65(12 Suppl 4):S74-7. PubMed ID: 16385108
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressing towards acceptable treatment outcomes.
    Vowles KE; Robinson ME
    Pain; 2009 Aug; 144(3):228-229. PubMed ID: 19500909
    [No Abstract]   [Full Text] [Related]  

  • 18. Cut-points for the measurement of pain: the choice depends on what you want to study.
    Farrar JT
    Pain; 2010 May; 149(2):163-164. PubMed ID: 20347224
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: A methodological survey.
    Mazzei LG; Bergamaschi CC; Silva MT; Barberato Filho S; Fulone I; Moura MDG; Guimaraes C; Lopes LC
    PLoS One; 2020; 15(4):e0231444. PubMed ID: 32298300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations.
    Edwards RR; Dworkin RH; Turk DC; Angst MS; Dionne R; Freeman R; Hansson P; Haroutounian S; Arendt-Nielsen L; Attal N; Baron R; Brell J; Bujanover S; Burke LB; Carr D; Chappell AS; Cowan P; Etropolski M; Fillingim RB; Gewandter JS; Katz NP; Kopecky EA; Markman JD; Nomikos G; Porter L; Rappaport BA; Rice ASC; Scavone JM; Scholz J; Simon LS; Smith SM; Tobias J; Tockarshewsky T; Veasley C; Versavel M; Wasan AD; Wen W; Yarnitsky D
    Pain; 2016 Sep; 157(9):1851-1871. PubMed ID: 27152687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.